Alvotech (ALVO) Cost of Revenue (2022 - 2025)
Alvotech (ALVO) reported Cost of Revenue of $61.3 million for Q4 2025, down 66.93% on a YoY basis from $185.3 million in Q4 2024, and up 75.06% quarter-over-quarter from $35.0 million in Q3 2025.
Alvotech (ALVO) Cost of Revenue (2022 - 2025) Analysis & Trends
Alvotech has reported Cost of Revenue for 4 years, with the latest figure at $61.3 million in Q4 2025.
- For the quarter ending Q4 2025, Cost of Revenue fell 66.93% year-over-year to $61.3 million; the trailing twelve-month figure through Dec 2025 stood at $235.6 million (down 18.85% YoY), and the FY2025 full-year result was $235.6 million, up 27.12% from the prior year.
- Cost of Revenue for Q4 2025 stood at $61.3 million, up from $35.0 million in the prior quarter.
- The five-year high for Cost of Revenue was $39.1 billion in Q1 2023, with the low at -$39.0 billion in Q2 2023.
- Historically, Cost of Revenue has averaged $57.6 million across 4 years, with a median of $62.7 million in 2022.
- The largest YoY upside for Cost of Revenue was 2236456.06% in 2023 against a maximum downside of 243032.41% in 2023.
- Alvotech's Cost of Revenue stood at $64.1 million in 2022, then soared by 150.96% to $160.9 million in 2023, then increased by 15.2% to $185.3 million in 2024, then sank by 66.93% to $61.3 million in 2025.
- The last three Cost of Revenue figures came in at $61.3 million (Q4 2025), $35.0 million (Q3 2025), and $73.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | Alvotech | 12.20 Mn | -160.16 Mn | -22.39 Mn | 61.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61.28 Mn |
| Dec 31, 2025 | 61.28 Mn |
| Sep 30, 2025 | 35.01 Mn |
| Sep 30, 2025 | 35.01 Mn |
| Jun 30, 2025 | 73.83 Mn |
| Jun 30, 2025 | 73.83 Mn |
| Mar 31, 2025 | 65.45 Mn |
| Mar 31, 2025 | 65.45 Mn |
| Dec 31, 2024 | 185.31 Mn |
| Dec 31, 2024 | 185.31 Mn |
| Sep 30, 2024 | 39.81 Mn |
| Sep 30, 2024 | 39.81 Mn |
| Jun 30, 2024 | -19.89 Bn |
| Jun 30, 2024 | -19.89 Bn |
| Mar 31, 2024 | 19.96 Bn |
| Mar 31, 2024 | 19.96 Bn |
| Dec 31, 2023 | 160.86 Mn |
| Dec 31, 2023 | 160.86 Mn |
| Aug 31, 2023 | 67.91 Mn |
| Aug 31, 2023 | 67.91 Mn |